World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: KCT
Last refreshed on: 11 March 2019
Main ID:  KCT0000448
Date of registration: 2012-05-24
Prospective Registration: No
Primary sponsor: Ewha Womans University Medical Center
Public title: Analysis of fecal microbiota and effectiveness of synbiotics in patients with functional constipation : C-club multicenter study
Scientific title: Analysis of fecal microbiota and effectiveness of synbiotics in patients with functional constipation : C-club multicenter study
Date of first enrolment: 2012-04-02
Target sample size: 60
Recruitment status: Recruiting
URL:  http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=2141
Study type:  Interventional Study
Study design:  Primary Purpose : Others, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : Not Applicable  
Phase:  Not applicable
Countries of recruitment
Korea, Republic of
Contacts
Name: Seong-Eun    Kim
Address: 
Telephone:
Email:
Affiliation:  Ewha Womans University Medical Center
Name: Seong-Eun    Kim
Address: 
Telephone:
Email:
Affiliation:  Ewha Womans University Medical Center
Key inclusion & exclusion criteria
Inclusion criteria: 1)20-60 year old patients
2)patients fulfilling Rome III criteria for functional constipation and their age- and sex-matched controls

Exclusion criteria: 1) pregnant or breastfeeding women
2) organic bowel disease
3) diagnosed with advanced adenoma within 3 years
4) irritable bowel disease(Rome III)
5) OP history of bowel surgery or cholecystectomy
6) lactose malabsorption
7) DM or severe medical disease(heart and lung, liver and kidney, malignancy, immunocompromised patients)
8)Heavy alcoholics
9)difficult to Cooperate
10) antibiotics, probiotics, or synbiotics within 1 month.


Age minimum: 20(Year)
Age maximum: 60(Year)
Gender: Both
Health Condition(s) or Problem(s) studied
Diseases of the digestive system
Intervention(s)
Dietary Supplement : Thirty patients fulfilling Rome III criteria for functional constipation and 30 controls were enrolled. Fecal samples were obtained before and after taking VSL#3 powder (450 billion lyophilizedbacteria/sachet twice a day) for 2 weeks.
The changes of stool consistency and spontaneous bowel movement frequency per week(SBMF) of patients were investigated using the Bristol stool form chart. Fecal microbiological analyses for 5 species (Lactobacillus, Bifidobacterium, Escherichia, Bacteroides and Clostridium spp.) were performed using quantitative real-time PCR.
Primary Outcome(s)
difference of gut microbiome between functional constipation and control, and the influences of a probiotic , VSL#3 on the microflora of each group
Secondary Outcome(s)
Influence of probiotics on bowel symptom of constipation patients
Secondary ID(s)
Source(s) of Monetary Support
NAMU, VSL#3
The Korean Society of Neurogastroenterology and Motility
Secondary Sponsor(s)
Ethics review
Status: Submitted approval
Approval date:
Contact:
Ewha Woman's University Mokdong Hospital Institutional Review Board
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history